Bioinformatics firm Ariadne Genomics, Inc., US, has announced the completion of a key partner programme with Illumina Inc. to provide advanced integration and interpretation capabilities for data generated from their iScan and BeadArray Reader platforms. The coupling of Ariadne's Pathway Studio to Illumina's next generation software, GenomeStudio Data Analysis Software, provides researchers with a toolset to quickly analyse expression data for physiological changes, cell signaling and other significant biological changes.
Pathway Studio provides academic and commercial clients with analytical capabilities for experimental data that provide biological context and mechanistic interpretation. Proprietary algorithms analyse experimental data to perform functional analysis, identify regulated pathways, or discover new biological networks. This bench-top application provides scientists a direct method to interpret their data, to formulate new hypotheses and to design new experiments.
The integration of Pathway Studio with Illumina's GenomeStudio Software improves the analysis workflow by rapidly characterising experimental data into meaningful results helping biologists develop new experiments and hypotheses. With the addition of advanced data analysis and pathway creation provided by Pathway Studio, Illumina's customers will achieve a significant research advantage by simplifying the transition from statistical data analysis to biological interpretation. In addition, Pathway Studio offers researchers a unique way to complete advanced downstream analysis by providing a graphical representation of Illumina's microarray data.
